368878-09-5

Basic information

• Product Name: C₅₄H₉₃N₃O₆Si₃
• Synonyms: C₅₄H₉₃N₃O₆Si₃
• CAS NO: 368878-09-5
• Molecular Weight: 964.605
• Mol File: 368878-09-5.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₅₄H₉₃N₃O₆Si₃(CAS DataBase Reference)
• NIST Chemistry Reference: C₅₄H₉₃N₃O₆Si₃(368878-09-5)
• EPA Substance Registry System: C₅₄H₉₃N₃O₆Si₃(368878-09-5)

Safety Data

• Hazardous Substances Data: 368878-09-5(Hazardous Substances Data)

Upstream product

• 368878-04-0 C₄₅H₇₂N₄O₆Si₂ 
• 368878-03-9 3-[1,3-bis-(tert-butyl-dimethyl-silanyloxy)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-ylmethoxy]-N,N-dimethyl-propionamide 
• 368878-13-1 3-[1,3-bis-(tert-butyl-dimethyl-silanyloxy)-10,13-dimethyl-2,3,4,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-ylmethoxy]-N,N-dimethyl-propionamide 
• 368878-02-8 1α,3β-bis(tert-butyldimethylsilyloxy)-17β-(hydroxymethyl)androst-5-ene 
• 368878-01-7 1α,3β-bis(tert-butyldimethylsilyloxy)-17-methyleneandrost-5-ene 
• 111594-61-7 1α,3β-bis<(tert-butyldimethylsilyl)oxy>androst-5-en-17-one 
• 4233-33-4 4-Phenyl-1,2,4-triazolidine-3,5-dione 
• 368878-05-1 C₄₀H₆₃N₃O₅Si₂ 

Relevant articles and documents

Synthesis of 21-nor-22-oxa-1Iα,25-dihydroxyvitamin D3 derivatives in quest of a drug with low calcemic activity

Two 21-nor-22-oxa-1α,25-dihydroxyvitamin D3 derivatives have been synthesized in quest of a drug with lower calcemic activity than Maxacalcitol, 22-oxa-1α,25-dihydroxyvitamin D3, being used as antihyperparathyroidism and antipsoriatic drug. Of two 21-nor products obtained, the product carrying one carbon elongated side chain with diethylcarbinol moiety has been found to exhibit comparable differentiation-inducing activity to Maxacalcitol with much lower exhibition of calcemic activity.